共 50 条
- [1] 6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children with Central Precocious Puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2021, 58
- [2] Efficacy and Safety of the First 6-Month Subcutaneous Leuprolide Acetate for Treatment of Central Precocious Puberty HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 171 - 172
- [3] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77
- [4] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77 : 241 - 242
- [5] 6-month Subcutaneous Leuprolide Acetate Increased Predicted Adult Height in Children with Central Precocious Puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2022, 64 : 160 - 160
- [6] 6-month Leuprolide Acetate for Monitoring Central Precocious Puberty Treatment Efficacy HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 208 - 209
- [7] 6-Month Subcutaneous Leuprolide Acetate Achieved and Maintained Hormonal and Clinical Suppression in All Weight Groups of Children with Central Precocious Puberty HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 285 - 287
- [9] Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10):